摘要
目的:探讨替格瑞洛在急性冠脉综合征介入治疗中的效果。方法:收治急性冠脉综合征患者98例,分为试验组与对照组,各49例。试验组患者接受替格瑞洛治疗,对照组患者接受氯吡格雷治疗。结果:试验组患者抑制血小板聚集效果明显优于对照组,且试验组心脑血管事件发生率明显低于对照组。结论:将替格瑞洛应用于冠脉综合征的临床治疗过程中,能够加速抗血小板聚集,且极大降低心脑血管事件的发生概率。
Objective:To investigate the effect of ticagrelor in interventional treatment of acute coronary syndrome.Methods:98patients with ACS were selected.They were divided into the experimental group and the control group with49cases in each.Theexperimental group received ticagrelor treatment.Patients in the control group received clopidogrel treatment.Results:Inhibition ofplatelet aggregation in the experimental group was significantly better than in the control group,and the incidence of adversecardiovascular events in the experimental group was significantly lower than that in the control group.Conclusion:Application ofticagrelor in the treatment of coronary syndrome can accelerate the role of anti platelet aggregation,and greatly reduce theincidence of adverse cardiovascular events.
作者
张建华
李辉
Zhang Jianhua;Li Hui(Development of Internal Medicine,Economic and Technological Zone Hospital of Handan City,Hebei Province 056000;Department of Internal Medicine-Cardiovascular,East Area of Handan Central Hospital,Hebei Province 056001)
出处
《中国社区医师》
2017年第12期30-30,32,共2页
Chinese Community Doctors
